Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma
Cancers · 07.02.2024 · 16 (4) · 698
DOI: 10.3390/cancers16040698 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 07.02.2024. Verfasst von Rishaan Pawaskar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Upper GI Surgery, Westmead Hospital, Sydney, NSW 2145, Australia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Perihilar cholangiocarcinoma (pCCA) is an uncommon malignancy with generally poor prognosis. Surgery is the primary curative treatment; however, the perioperative mortality and morbidity rates are high, with a low 5-year survival rate. Use of preoperative prognostic biomarkers to predict survival outcomes after surgery for pCCA are not well-established currently. This systematic review aimed to identify and summarise preoperative biomarkers associated with survival in pCCA, thereby potentially improving treatment decision-making. The Embase, Medline, and Cochrane databases were searched, and a systematic review was performed using the PRISMA guidelines. English-language studies examining the association between serum and/or tissue-derived biomarkers in pCCA and overall and/or disease-free survival were included. Our systematic review identified 64 biomarkers across 48 relevant studies. Raised serum CA19-9, bilirubin, CEA, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and tumour MMP9, and low serum albumin were most associated with poorer survival; however, the cutoff values used widely varied. Several promising molecular markers with prognostic significance were also identified, including tumour HMGA2, MUC5AC/6, IDH1, PIWIL2, and DNA index. In conclusion, several biomarkers have been identified in serum and tumour specimens that prognosticate overall and disease-free survival after pCCA resection. These, however, require external validation in large cohort studies and/or in preoperatively obtained specimens, especially tissue biopsy, to recommend their use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Upper GI Surgery, Westmead Hospital, Sydney, NSW 2145, Australia.
- Westmead Hospital, Sydney, NSW 2145, Australia.
- Surgical Innovations Unit, Westmead Hospital, Sydney, NSW 2145, Australia.
- Westmead Clinical School, Faculty of Medicine and Health Sciences, The University of Sydney, Sydney, NSW 2006, Australia.
- Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, NSW 2145, Australia.
- Macquarie University Medical School, Macquarie University, Sydney, NSW 2145, Australia.
ORCID-Profile: Christopher B Nahm
Zitieren
APA
Pawaskar, R., Huang, K. Z., Pham, H., Nagrial, A., Wong, M., O'Neill, S., Pleass, H., Yuen, L., Lam, V. W. T., Richardson, A., Pang, T., & Nahm, C. B. (2024). Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma. Cancers, 16(4), 698. https://doi.org/10.3390/cancers16040698
Vancouver
Pawaskar R, Huang KZ, Pham H, Nagrial A, Wong M, O'Neill S, et al. Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma. Cancers. 2024;16(4):698. doi:10.3390/cancers16040698
BibTeX
@article{Pawaskar2024,
author = {Pawaskar, Rishaan and Huang, Kevin Zhang and Pham, Helen and Nagrial, Adnan and Wong, Mark and O'Neill, Siobhan and Pleass, Henry and Yuen, Lawrence and Lam, Vincent W T and Richardson, Arthur and Pang, Tony and Nahm, Christopher B},
title = {Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma},
journal = {Cancers},
year = {2024},
volume = {16},
number = {4},
pages = {698},
doi = {10.3390/cancers16040698}
}
EUVIMED